Oncocyte Corp Annual Operating Margin in % from 2020 to 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Oncocyte Corp quarterly/annual Operating Margin history and growth rate from 2020 to 2024.
  • Oncocyte Corp Operating Margin for the quarter ending December 31, 2024 was -3.25K %, a 94% decline year-over-year.
  • Oncocyte Corp annual Operating Margin for 2024 was -3.25K %, a 94% decline from 2023.
  • Oncocyte Corp annual Operating Margin for 2023 was -1.67K %, a 11% increase from 2022.
  • Oncocyte Corp annual Operating Margin for 2022 was -1.88K %, a 23.1% increase from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -3.25K -1.57K -94% Jan 1, 2024 Dec 31, 2024
2023 -1.67K +206 +11% Jan 1, 2023 Dec 31, 2023
2022 -1.88K +566 +23.1% Jan 1, 2022 Dec 31, 2022
2021 -2.44K -0.93 -0.04% Jan 1, 2021 Dec 31, 2021
2020 -2.44K Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.